Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Huilin Huang; Yilin Xu; Chonghui Cheng

doi:10.3791/51845

Nachweis von Alternative Splicing Während Epithelial-mesenchymale Transition

JoVE Journal
Biology

A subscription to JoVE is required to view this content. Sign in or start your free trial.

JoVE Journal Biology

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Nachweis von Alternative Splicing Während Epithelial-mesenchymale Transition

Full Text

13,435 Views

11:48 min

October 9, 2014

DOI: 10.3791/51845-v

Huilin Huang*¹, Yilin Xu*¹, Chonghui Cheng¹

¹Division of Hematology/Oncology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center,Northwestern University Feinberg School of Medicine

Please note that some of the translations on this page are AI generated. Click here for the English version.

Overview

This study investigates the role of alternative splicing during the epithelial-mesenchymal transition (EMT), a critical process in various biological contexts. Using an inducible EMT model, the research aims to detect changes in splicing patterns associated with EMT.

Key Study Components

Area of Science

Neuroscience
Cell Biology
Oncology

Background

Alternative splicing is a regulatory mechanism influencing gene expression.
EMT is essential for development and cancer progression.
Understanding splicing changes can provide insights into EMT regulation.
EMT is linked to tumor invasion and metastasis.

Purpose of Study

To detect changes in alternative splicing during EMT.
To analyze the regulation of splicing in relation to EMT.
To explore implications for cancer therapy.

Methods Used

Inducible EMT model using human mammary epithelial cells.
Tamoxifen treatment to trigger EMT.
Quantitative RT-PCR with isoform-specific primers to analyze splicing.
Immunoblotting to confirm protein expression of splice isoforms.

Main Results

Changes in alternative splicing were detected in genes of interest during EMT.
Results from quantitative RT-PCR and immunoblotting confirmed splicing alterations.
The study provides insights into the regulation of splicing during EMT.
Findings have potential implications for understanding tumor biology.

Conclusions

Alternative splicing plays a significant role in EMT regulation.
This method can help answer critical questions in splicing and EMT research.
Understanding these mechanisms may aid in developing cancer therapies.

Frequently Asked Questions

What is alternative splicing?

Alternative splicing is a process that allows a single gene to produce multiple protein isoforms by including or excluding certain RNA sequences.

Why is EMT important?

EMT is crucial for various biological processes, including development, wound healing, and cancer metastasis, as it enables cells to acquire migratory and invasive properties.

How does the inducible EMT model work?

The inducible EMT model uses a fusion protein that triggers the EMT process in response to a specific treatment, allowing researchers to study splicing changes during this transition.

What techniques are used to analyze splicing?

Quantitative RT-PCR and immunoblotting are employed to analyze RNA and protein levels of splice isoforms, respectively.

What are the implications of this research?

The findings may provide insights into the regulation of splicing during EMT and its role in cancer progression, potentially informing therapeutic strategies.

Es wurde gezeigt, dass die alternative Spleißregulation zum epithelial-mesenchymalen Übergang (EMT) beiträgt, einem essentiellen zellulären Programm in verschiedenen physiologischen und pathologischen Prozessen. Hier beschreiben wir ein Verfahren, das ein induzierbares EMT-Modell zur Detektion von alternativem Spleißen während der EMT verwendet.

Das übergeordnete Ziel des folgenden Experiments ist es, Veränderungen im alternativen Spleißen während der EMT zu erkennen. Dies wird durch die Verwendung eines induzierbaren EMT-Modells erreicht, in dem die Expression des Fusionsproteins verdreht ist. In der menschlichen Brust lösen Epithelzellen die Zellen aus, sich in einem zweiten Schritt einer EMT zu unterziehen, nachdem Tamoxifen

Die Expression von Spleißisoformen wird durch quantitatives R-T-P-C-R unter Verwendung isoformspezifischer Primersätze analysiert, was alternative Spleißänderungen auf RNA-Ebene aufzeigt. Als nächstes wird die Häufigkeit des Proteins, das jeder Isoform entspricht, durch Immunblotting bestimmt, um die Expression von Spleißisoformen auf Proteinebene zu bestätigen, es werden Ergebnisse erhalten, die Veränderungen im alternativen Spleißen in Genen von Interesse während der EMT zeigen, basierend auf quantitativen R-T-P-C-R- und Immunblotting-Analysen. Diese Methode kann dazu beitragen, Schlüsselfragen auf dem Gebiet des alternativen Spleißens von RN und EMT zu beantworten. z.B. wie alternatives Spleißen während der EMT reguliert wird und wie sich diese Regulation auf EMT und EMT-bedingte pathologische Prozesse auswirkt. Die Implikationen dieser Technik sind für die Krebstherapie, da EMT eine wichtige Rolle bei der Förderung der Tumorinvasion und Metastasierung spielt.

View the full transcript and gain access to thousands of scientific videos